Literature DB >> 24319726

Aptamer RA36 inhibits of human, rabbit, and rat plasma coagulation activated with thrombin or snake venom coagulases.

E Yu Savchik1, T B Kalinina, N N Drozd, V A Makarov, E G Zav'yalova, E N Lapsheva, N N Mudrik, A V Babij, G V Pavlova, A V Golovin, A M Kopylov.   

Abstract

RA36 DNA aptamer is a direct anticoagulant prolonging clotting time of human, rabbit, and rat plasma in the thrombin time test. Anticoagulant activity of RA36 is lower than that of recombinant hirudin. During inhibition of human plasma clotting activated with echitox (coagulase from Echis multisquamatus venom), the aptamer presumably binds to meisothrombin exosite I. The sensitivity of human plasma to the aptamer 5-fold surpasses that of rat plasma. Analysis of RA36 binding to coagulase of Agkistrodon halys venom (ancistron) is required for proving the effect of aptamer on polymerization of human fibrinogen.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24319726     DOI: 10.1007/s10517-013-2274-2

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  4 in total

Review 1.  Trends in the Design and Development of Specific Aptamers Against Peptides and Proteins.

Authors:  Maryam Tabarzad; Marzieh Jafari
Journal:  Protein J       Date:  2016-04       Impact factor: 2.371

2.  Rapidly Neutralizable and Highly Anticoagulant Thrombin-Binding DNA Aptamer Discovered by MACE SELEX.

Authors:  Koji Wakui; Toru Yoshitomi; Akane Yamaguchi; Maho Tsuchida; Shingo Saito; Masami Shibukawa; Hitoshi Furusho; Keitaro Yoshimoto
Journal:  Mol Ther Nucleic Acids       Date:  2019-03-22

Review 3.  Applications in Which Aptamers Are Needed or Wanted in Diagnostics and Therapeutics.

Authors:  John G Bruno
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-01

4.  Exploring the Utility of ssDNA Aptamers Directed against Snake Venom Toxins as New Therapeutics for Snakebite Envenoming.

Authors:  Nessrin Alomran; Raja Chinnappan; Jaffer Alsolaiss; Nicholas R Casewell; Mohammed Zourob
Journal:  Toxins (Basel)       Date:  2022-07-08       Impact factor: 5.075

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.